Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$796K Sell
33,067
-424
-1% -$11.1K 0.1% 98
2026
Q1
$940K Sell
33,491
-1,670
-5% -$44.5K 0.14% 78
2025
Q4
$876K Sell
35,161
-2,714
-7% -$68.4K 0.13% 81
2025
Q3
$965K Sell
37,875
-418
-1% -$10.3K 0.15% 71
2025
Q2
$928K Sell
38,293
-389
-1% -$9.07K 0.15% 63
2025
Q1
$980K Sell
38,682
-3,352
-8% -$87.7K 0.17% 58
2024
Q4
$1.12M Sell
42,034
-5,215
-11% -$141K 0.19% 58
2024
Q3
$1.37M Sell
47,249
-1,570
-3% -$45.8K 0.24% 50
2024
Q2
$1.37M Sell
48,819
-564
-1% -$15.5K 0.25% 51
2024
Q1
$1.37M Sell
49,383
-2,722
-5% -$75.5K 0.3% 46
2023
Q4
$1.5M Sell
52,105
-155
-0.3% -$4.69K 0.32% 44
2023
Q3
$1.73M Sell
52,260
-11
-0% -$389 0.41% 37
2023
Q2
$1.92M Buy
52,271
+765
+1% +$29.8K 0.45% 32
2023
Q1
$2.1M Buy
51,506
+373
+0.7% +$16.1K 0.52% 32
2022
Q4
$2.62M Buy
51,133
+459
+0.9% +$22K 0.9% 24
2022
Q3
$2.22M Sell
50,674
-184
-0.4% -$8.94K 0.75% 25
2022
Q2
$2.67M Buy
50,858
+1,544
+3% +$78.7K 0.89% 23
2022
Q1
$2.55M Sell
49,314
-3,150
-6% -$163K 0.71% 23
2021
Q4
$3.1M Buy
52,464
+442
+0.8% +$21.9K 0.87% 22
2021
Q3
$2.24M Buy
52,022
+136
+0.3% +$6.03K 0.67% 29
2021
Q2
$2.03M Sell
51,886
-43
-0.1% -$1.67K 0.6% 30
2021
Q1
$1.88M Sell
51,929
-3,023
-6% -$107K 0.59% 29
2020
Q4
$2.02M Sell
54,952
-4,142
-7% -$152K 0.66% 27
2020
Q3
$2.06M Sell
59,094
-41,925
-42% -$1.47M 0.76% 25
2020
Q2
$3.13M Sell
101,019
-1,709
-2% -$58.1K 1.14% 18
2020
Q1
$3.18M Buy
102,728
+8,866
+9% +$302K 1.25% 17
2019
Q4
$3.48M Buy
93,862
+1,442
+2% +$51.4K 1.16% 18
2019
Q3
$3.15M Buy
92,420
+2,634
+3% +$95.8K 1.12% 19
2019
Q2
$3.69M Buy
89,786
+1,538
+2% +$61.1K 1.33% 16
2019
Q1
$3.56M Sell
88,248
-228
-0.3% -$9.13K 1.28% 18
2018
Q4
$3.61M Buy
88,476
+1,388
+2% +$57.6K 1.5% 15
2018
Q3
$3.64M Buy
87,088
+7,006
+9% +$270K 1.41% 14
2018
Q2
$2.76M Buy
80,082
+49
+0.1% +$1.67K 1.1% 20
2018
Q1
$2.69M Sell
80,033
-6,436
-7% -$221K 1.12% 18
2017
Q4
$2.97M Sell
86,469
-246
-0.3% -$8.39K 1.3% 16
2017
Q3
$2.94M Buy
86,715
+3,700
+4% +$119K 1.37% 13
2017
Q2
$2.65M Buy
83,015
+2,521
+3% +$79.5K 1.36% 13
2017
Q1
$2.61M Buy
80,494
+9,717
+14% +$306K 1.4% 13
2016
Q4
$2.18M Sell
70,777
-3,585
-5% -$109K 1.23% 15
2016
Q3
$2.39M Sell
74,362
-2,968
-4% -$99.2K 1.35% 13
2016
Q2
$2.58M Buy
77,330
+14,924
+24% +$476K 1.41% 13
2016
Q1
$1.75M Buy
62,406
+5,458
+10% +$156K 0.97% 19
2015
Q4
$1.74M Buy
56,948
+536
+1% +$16.9K 0.78% 22
2015
Q3
$1.68M Buy
56,412
+16,128
+40% +$517K 0.79% 21
2015
Q2
$1.28M Buy
40,284
+201
+0.5% +$6.55K 0.58% 21
2015
Q1
$1.32M Sell
40,083
-8,571
-18% -$272K 0.59% 22
2014
Q4
$1.44M Buy
48,654
+19,482
+67% +$559K 0.66% 23
2014
Q3
$818K Buy
29,172
+2,789
+11% +$78.3K 0.51% 31
2014
Q2
$743K Buy
26,383
+651
+3% +$18.6K 0.85% 22
2014
Q1
$784K Buy
25,732
+137
+0.5% +$4.08K 0.65% 18
2013
Q4
$744K Buy
25,595
+827
+3% +$24.1K 0.63% 20
2013
Q3
$675K Sell
24,768
-820
-3% -$22.3K 0.65% 21
2013
Q2
$680K Buy
+25,588
New +$707K 1% 18

Other funds holding PFE

Hudock Inc's PFE Position: Q2 2026 in Review

Hudock Inc reduced its Pfizer (PFE) stake by 1.3% in Q2 2026, selling an estimated $11.1K and leaving 33,067 shares worth $796K. The position accounts for 0.1% of the portfolio, ranked #98.

Hudock Inc first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.69M in Q2 2019. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hudock Inc held 33,067 shares of Pfizer worth $796K as of Q2 2026.
  • Hudock Inc sold 424 Pfizer shares in Q2 2026, an estimated $11.1K.
  • Pfizer made up 0.1% of Hudock Inc's portfolio in Q2 2026, its #98 holding.
  • Hudock Inc first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Hudock Inc's Pfizer position peaked at $3.69M in Q2 2019.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hudock Inc's 13F filing for Q2 2026, filed 31 Jul 2026.